Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran.

Abstract

We examined the therapeutic effects of albendazole compared to metronidazole in 120 patients with giardiasis in Hamdan. Patients were randomized to receive albendazole (400 mg, once daily for 5 days) or metronidazole (250 mg, 3 times a day for 5 days). Demographic data of the patients, results of stool examination for Giardia trophozoites before and after treatment, and drug side-effects were recorded. After treatment 6 (10.0%) of the albendazole group had trophozoites compared with 14 (23.3%) of metronidazole group (P < 0.05). Patients in the albendazole group had fewer side-effects while 43.3% of the metronidazole group experienced a metallic taste and 35.0% experienced loss of appetite. Albendazole is an easy, safe and effective treatment for giardiasis.

• Authors: A Alizadeh, M Ranjbar, K M Kashani, M M Taheri, M Bodaghi
• Journal: Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit (East Mediterr Health J) Vol. 12 Issue 5 Pg. 548-54 (Sep 2006) ISSN: 1020-3397 [Print] Egypt
• PMID: 17333792 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)

Chemical References

• Antiprotozoal Agents
• Metronidazole
• Albendazole

Topics

• Adolescent
• Adult
• Albendazole (adverse effects, therapeutic use)
• Anorexia (chemically induced)
• Antiprotozoal Agents (adverse effects, therapeutic use)
• Child
• Child, Preschool
• Drug Administration Schedule
• Feces (parasitology)
• Female
• Follow-Up Studies
• Giardiasis (drug therapy, parasitology)
• Humans
• Iran
• Male
• Metronidazole (adverse effects, therapeutic use)
• Middle Aged
• Safety
• Single-Blind Method
• Taste Disorders (chemically induced)
• Treatment Outcome
• Urban Health